poisar

Stocks · News reference

Bioventus Reports Third Quarter 2026 Financial Results

Fiscal.ai

Bioventus Inc. announced its financial results for the third quarter of 2026, reporting $142.4 million in revenue and $0.17 in non-GAAP earnings per diluted share.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Bioventus Inc. (BVS)

    Filed: 2026-11-02 AccNo: 0001665988-26-000050 Size: 838 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits